Autolus Therapeutics (AUTL) Receivables - Other (2017 - 2025)
Autolus Therapeutics (AUTL) has disclosed Receivables - Other for 8 consecutive years, with $936000.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Other rose 56.52% year-over-year to $936000.0, compared with a TTM value of $936000.0 through Sep 2025, up 56.52%, and an annual FY2024 reading of $1.4 million, up 175.39% over the prior year.
- Receivables - Other was $936000.0 for Q3 2025 at Autolus Therapeutics, up from $665000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $2.4 million in Q3 2023 and bottomed at $2000.0 in Q4 2022.
- Average Receivables - Other over 5 years is $817727.3, with a median of $665000.0 recorded in 2025.
- The sharpest move saw Receivables - Other crashed 99.48% in 2022, then surged 25700.0% in 2023.
- Year by year, Receivables - Other stood at $384000.0 in 2021, then plummeted by 99.48% to $2000.0 in 2022, then soared by 25700.0% to $516000.0 in 2023, then skyrocketed by 175.39% to $1.4 million in 2024, then plummeted by 34.13% to $936000.0 in 2025.
- Business Quant data shows Receivables - Other for AUTL at $936000.0 in Q3 2025, $665000.0 in Q2 2025, and $423000.0 in Q1 2025.